Prior authorization has long been a barrier to timely cancer diagnostics and treatment. Oncology labs like Exact Sciences face unique challenges: aggressive and inconsistent payer criteria, rising denial rates, and long turnaround times for critical tests. Before Infinx, these issues led to delays, staff strain, and revenue at risk.
Through a collaborative partnership, Exact Sciences has streamlined PA processes by:
- Tackling denial drivers such as insufficient clinical criteria and missing pathology reports.
- Reducing pending-review backlogs and turnaround times, even for Medicaid and unlisted codes.
- Scaling efficiently with flexible onshore/offshore resources.
Leveraging automation and AI behind the scenes to classify cases, capture missing documents, and align with payer rules.
This Office Hours will highlight Liz Durkin, Manage of Revenue Cycle as she tells the story of Exact Sciences’ journey, from pain points to progress, and provide takeaways for other oncology organizations seeking to change the narrative on prior authorization.
Join us this Thursday, November 13, 2025
11am PT / 1:00pm CT / 2:00pm ET
Register your secure spot.